Page last updated: 2024-09-03

methylthio-adp and colforsin

methylthio-adp has been researched along with colforsin in 2 studies

Compound Research Comparison

Studies (methylthio-adp)	Trials (methylthio-adp)	Recent Studies (post-2010) (methylthio-adp)	Studies (colforsin)	Trials (colforsin)	Recent Studies (post-2010) (colforsin)
146	2	43	13,460	46	1,298

Protein Interaction Comparison

Protein	Taxonomy	colforsin (IC50)
nuclear receptor subfamily 0 group B member 1	Homo sapiens (human)	1.729
5-hydroxytryptamine receptor 1A	Homo sapiens (human)	0.041
Adenylate cyclase type 1	Homo sapiens (human)	0.0955

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baqi, Y; Glänzel, M; Hoffmann, K; Morena, MS; Müller, CE; von Kügelgen, I	1
Baqi, Y; Hoffmann, K; Lutz, DA; Müller, CE; Straßburger, J; von Kügelgen, I	1

Other Studies

2 other study(ies) available for methylthio-adp and colforsin

Article	Year
Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:2 Topics: Adenosine Diphosphate; Animals; Arginine; Binding, Competitive; CHO Cells; Cloning, Molecular; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclic AMP Response Element Modulator; Humans; Isomerism; Luciferases; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Sulfonic Acids; Suramin; Thionucleotides; Triazines	2009
Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:11 Topics: Adenosine; Adenosine Diphosphate; Animals; Binding Sites; Binding, Competitive; CHO Cells; Colforsin; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Mutation; Platelet Aggregation Inhibitors; Protein Binding; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Response Elements; Thionucleotides; Ticagrelor; Transfection	2014

Article

Year

Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor.

The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:2

Topics: Adenosine Diphosphate; Animals; Arginine; Binding, Competitive; CHO Cells; Cloning, Molecular; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclic AMP Response Element Modulator; Humans; Isomerism; Luciferases; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Sulfonic Acids; Suramin; Thionucleotides; Triazines

2009

Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.

Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:11

Topics: Adenosine; Adenosine Diphosphate; Animals; Binding Sites; Binding, Competitive; CHO Cells; Colforsin; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Mutation; Platelet Aggregation Inhibitors; Protein Binding; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Response Elements; Thionucleotides; Ticagrelor; Transfection

2014